Attività di ricerca

From 2019: investigator of a randomized, double-blind, placebo controlled multicenter trial to assess the
safety and efficacy of multiple CFZ533 doses administered subcutaneously in two distinct populations of
patients with Sjögren's Syndrome (TWINSS).
From 2019: sub-investigator of a phase 4, multicenter, randomized, doubleblind, placebo-controlled,
parallel-group study to evaluate the efficacy and safety of apremilast (CC-10004) in subjects with early,
oligoarticular psoriatic arthritis despite initial stable treatment with either NSAIDs and/or 1 conventional
synthetic DMARD.
From 2019: joint evaluator of a Phase 2 Dose Ranging Study to Evaluate the Efficacy and Safety of AMG
570 in Subjects With Active Systemic Lupus Erythematosus (SLE) with Inadequate Response to
Standard of Care (SOC) Therapy.
From 2019: sub-invetigator of a randomized, double-blind, double-dummy, active-controlled multicenter,
2-part phase II study on replacement of steroids by IFX-1 in active granulomatosis with polyangiitis (GPA)
and microscopic polyangiitis (MPA).
From 2019 to 2020 : investigator of GO-BEYOND-Italy: a prospective observational study to assess the
real world effectiveness of golimumab (GLM) in patients with active rheumatoid arthritis (RA), psoriatic
arthritis (PsA), or axial Spondyloarthritis (axSpA) and failure of an initial tumor necrosis factor alpha
inhibitor (TNFai) therapy.
From 2019: sub-investigator of a phase 2b, multicenter, randomized, double blind, placebo-controlled,
parallel-group, dose finding study to evaluate the efficacy and safety of cenerimod in subjects with
moderate or severe systemic lupus erythematosus (SLE).
From 2019 to 2021: sub-investigator of a prospective, observational study, in patients with a newly
confirmed diagnosis of spondyloarthritis (SpA) according to ASAS criteria, naïve to conventional
(cDMARDs), targeted (tsDMARDs) and biological DMARDs (bDMARDs) (SIRENA Study)
From 2020 to 2021: sub-investigator of INTERCOP a randomized, controlled, open label, phase 2 clinical
trial of Interferon- -1a (IFN -1a) in COVID-19 patients.
From 2021: investigator of the SAVE-MORE: SUPAR-guided ANAKINRA treatment for validation of the risk
and early management of severe respiratory failure by COVID-19 a double-blind, randomized, phase III
confirmatory trial.
From 2021: sub-investigator of COV-AD study: COVID infection in patients with antibody deficiency
[COVID-19].

From2023: investigator in   a  Phase II, Randomised, Placebo-controlled, Double-blind, Parallel Group, Efficacy and Safety Study of at Least 48 Weeks of Oral BI 685509 Treatment in Adults With Progressive Systemic Sclerosis VITALISScE

From April 2020 to November 2020: translational research project on 'evaluating the persistence of
circulating T-follicular helper cells subsets and the CXCL13 levels after Rituximab therapy in relapsing IgG4-related disease'

From June 2021 to October 2021: laboratory working experience as a Clinical Research Fellow at UCL's Laboratory on ' the development deep phenotyping and functional assays to compliment genetic analysis
and improve the ability to identify patients suitable for tailored cell and gene therapy in primary immunedeficiencies

Junior Member of the European Society for Immunodeficiencies (ESID)
Junior Member of British Society for Immunology (BSI)
Junior Member of Società Italiana di Allergologia Asma e Immunologia Clinica (SIAAIC)
EULAR (European League Against Rheumatism) School member
Junior Member of The European Academy of Allergy and Clinical Immunology (EAACI)

Feb 2024 for BMC Neurology
Sept 2023 for BMC Rheumatology
Mar 2021 for BMJ Case Reports
Feb 2021for European Journal of Haematology

Dec 2020 for Journal of International Medical Research
Mar 2020 for European Journal of Haematology
Nov 2019 for The Journal of Rheumatology
Nov 2019 for Medical Science Monitor

2023

tutoraggio in Ecografia muscolo tendinea e delle parti molli per un totale di 70 ore col Prof. Roberto Azzoni dal 02/04/2023 al 31/07/2023

​

2023

Corso di ecografia in Reumatologia

Dynamicom Education S.R.L

​

2022

Corso di ecografia muscoloscheletrica e articolare

Edi.ermes

​

2020

Assessment of Enthesitis and Dactylitis in Psoriatic Arthritis

GRAPPA Group for Research and Assessment of Psoriasis and Psoriatic Arthritis

​

2019 e 2023

ICH Good Clinical Practice E6 (R2)

Global Health Training Centre

​

2016

BLS

American Heart Association

​

2015

IELTS - British Counciil

Livello europeo: B2

​​

2009

1° Classified Chemistry games Scientific High SchoolPitagora

Calabria University

​